Clinical Trial Update: Study of VX-770 on Desipramine [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the interaction between ivacaftor (VX-770) and desipramine in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Kalydeco (ivacaftor)
• NORPRAMIN (Desipramine hydrochloride)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: In Development for Cystic Fibrosis | Phase 1 | Status: COMPLETED